Synthesis and nicotinic receptor activity of chemical space analogues of N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-4-chlorobenzamide (PNU-282,987) and 1,4-diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester (SSR180711). 2012

Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
Department of Chemistry and Biochemistry, University of Berne , Freiestrasse 3, 3012 Berne, Switzerland.

The Chemical Universe Generated Databases up to 11 atoms of CNOF (GDB-11) and up to 13 atoms of CNOClS (GDB-13) were used to enumerate analogues of the diamine part of two known α7 nicotinic receptor agonists and construct libraries of virtual analogues of these drugs. The libraries were scored using structure-based (docking to the nicotine binding site of the acetylcholine binding protein 1uw6.pdb) or ligand-based (similarity to the parent drugs) methods, and the top-scoring virtual ligands were inspected for easily accessible synthetic targets. In total, 21 diamines were prepared and acylated with aromatic carboxylic or oxycarbonic acids to produce 85 analogues of the parent drugs. The compounds were profiled by electrophysiology in Xenopus oocytes expressing human nicotinic acetylcholine receptor (nAChR) subtypes α7, α3β2, α4β2, α3β4, or α4β4. Characterization of selected compounds revealed eight inhibitors of the α7 nicotinic receptor and three positive allosteric modulators of the α3β2 nAChR.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001549 Benzamides BENZOIC ACID amides.
D001643 Bridged Bicyclo Compounds Saturated alicyclic hydrocarbon molecules consisting of two rings that have two non-adjacent atoms in common. Bicyclo Compounds,Bicyclo Compounds, Bridged
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining

Related Publications

Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
January 2016, Journal of pharmaceutical sciences,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
March 2005, The Journal of pharmacology and experimental therapeutics,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
May 2008, The Journal of organic chemistry,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
January 1977, Arzneimittel-Forschung,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
May 2013, Psychopharmacology,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
August 2009, Bioorganic & medicinal chemistry letters,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
May 2007, The Journal of pharmacology and experimental therapeutics,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
January 1979, Journal of medicinal chemistry,
Lise Bréthous, and Noemi Garcia-Delgado, and Julian Schwartz, and Sonia Bertrand, and Daniel Bertrand, and Jean-Louis Reymond
February 1998, Nuclear medicine and biology,
Copied contents to your clipboard!